| Basics |
|
Immunic, Inc.
|
| IPO Date: |
April 14, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$79.94M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 4.00%
|
| Avg Daily Range (30 D): |
$0.03 | 3.93%
|
| Avg Daily Range (90 D): |
$0.03 | 3.66%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.63M |
| Avg Daily Volume (30 D): |
1.07M |
| Avg Daily Volume (90 D): |
1.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
193 |
| Avg Trade Size (Sh.) (30 D): |
309 |
| Avg Trade Size (Sh.) (90 D): |
329 |
| Institutional Trades |
| Total Inst.Trades: |
84 |
| Avg Inst. Trade: |
$2.1M |
| Avg Inst. Trade (30 D): |
$3.23M |
| Avg Inst. Trade (90 D): |
$3.23M |
| Avg Inst. Trade Volume: |
.35M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.64M |
| Avg Closing Trade (30 D): |
$.51M |
| Avg Closing Trade (90 D): |
$.51M |
| Avg Closing Volume: |
345.3K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.13
|
$-.2
|
$-.25
|
|
Diluted EPS
|
$-.13
|
$-.2
|
$-.25
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -25.58M
|
$ -26.82M
|
$ -25.47M
|
|
Operating Income / Loss
|
$ -25.99M
|
$ -27.08M
|
$ -26.83M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -20.18M
|
$ 20.1M
|
$ -.46M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Apr 15, 2019:
1:40
|
|
|
|